| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016601 |
| Receipt No. | R000019265 |
| Official scientific title of the study | A randomized controlled study to examine the effects of a triple therapy with vonoprazan or rabeprazole against standard triple therapy-failed patients. |
| Date of disclosure of the study information | 2015/02/26 |
| Last modified on | 2018/08/06 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | A randomized controlled study to examine the effects of a triple therapy with vonoprazan or rabeprazole against standard triple therapy-failed patients. | |
| Title of the study (Brief title) | A triple therapy with vonoprazan or rabeprazole against standard triple therapy-failed patients | |
| Region |
|
|
| Condition | ||
| Condition | Helicobacter pylori infection | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Comparison between a triple therapy with vonoprazan and a triple therapy with rabeprazole against standard triple therapy-failed patients, and investigation of their adverse effects. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Comparison on an eradication rate between a triple therapy with vonoprazan and a triple therapy with rabeprazole |
| Key secondary outcomes | Comparison of adverse effects between a triple therapy with vonoprazan and a triple therapy with rabeprazole |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | vonoprazan, metronidazole, amoxicillin | |
| Interventions/Control_2 | rabeprazole, metronidazole, amoxicillin | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who failed standard triple therapy | |||
| Key exclusion criteria | 1. Patients who cannot cancel a proton pump inhibitor for 2 weeks before judgment after re-eradication therapy.
2. Patients who have past history of drug allergy. 3. Patients who have severe diseases affecting the kidney, the heart, and the liver. 4. Patients who are pregnant, who may be pregnant, or who are nursing. |
|||
| Target sample size | 70 | |||
| Research contact person | |
| Name of lead principal investigator | Mariko Hojo |
| Organization | Juntendo University School of Medicine |
| Division name | Department of Gastroenterology |
| Address | 2-1-1Hongo,Bunkyo-ku,Tokyo 113-8421, Japan |
| TEL | 03-3813-3111 |
| mhojo@juntendo.ac.jp | |
| Public contact | |
| Name of contact person | Mariko Hojo |
| Organization | Juntendo University School of Medicine |
| Division name | Department of Gastroenterology |
| Address | 2-1-1Hongo,Bunkyo-ku,Tokyo 113-8421, Japan |
| TEL | 03-3813-3111 |
| Homepage URL | |
| mhojo@juntendo.ac.jp | |
| Sponsor | |
| Institute | Juntendo University School of Medicine, Department of Gstroenterology |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Juntendo University School of Medicine, Department of Gstroenterology |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 順天堂大学医学部附属順天堂医院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019265 |